Cellular replacement therapy for liver disease
Author: Saliem, Mohammed Abdel Salam M
Date: 2013-04-23
Location: Föreläsningssal R64 på Karolinska Universitetssjukhuset, Huddinge
Time: 13.30
Department: Inst för klinisk vetenskap, intervention och teknik / Dept of Clinical Science, Intervention and Technology
Abstract
Liver disease is a major health problem worldwide. The liver performs a wide range of functions, which the human body cannot survive without. The human liver is continuously challenged with infectious organisms, alcohol and chemicals, congenital defects, autoimmunity and malignancy etc. The liver has been imparted a marvelous capacity to regenerate and recover from various insults. However, in many cases liver injuries exceed its regenerative capacity with end-stage liver disease becoming the inevitable end. So far, liver transplantation is still the only treatment modality for end-stage liver disease. However, there are many limitations to liver transplantation towards its applicability and availability for all patients worldwide, such as scarcity of donors as well as other ethical, technical and surgical considerations.
Cell transplantation is a frequently studied alternative to organ transplantation in liver disease. Many cell types are under extensive evaluation, with primary human hepatocytes and different stem cell types coming first on the list. For primary human hepatocytes, liver tissue is still needed, and when available, cells are produced in huge numbers requiring cryopreservation. Available hepatocyte cryopreservation protocols still need further optimization. In addition, better cold storage techniques for hepatocytes are needed for the feasibility of frequent cell infusions per patient. Stem cells still need to be studied further for their differentiation potential towards hepatic lineages, safety, immunomodulatory roles, and their possible support for co- transplanted hepatocytes.
In this thesis, we addressed a few of the current obstacles facing cellular replacement therapy for liver disease. In the first study, we isolated and characterized a mesenchymal stem cell population from human fetal liver. The hepatic origin, the mesenchymal nature, and the immunomodulatory effects of these cells suggest them as potential candidates for cellular therapy for liver disease. In addition, we transplanted these cells into a mouse model of liver disease with an evidence for their potential differentiation to hepatocyte-like cells in vivo. In the second study, we characterized microRNAs expressed in the human liver. Such information can help understanding the role of microRNAs in liver development and their potential use in microRNA-based stem cell differentiation towards hepatic lineages. In the third study, we introduced a new defined xeno-free cryoprotectant to the field of hepatocyte cryopreservation. This cryoprotectant could be of value when preserving hepatocytes and stem cell-derived hepatocytes in a clinical setting. In the fourth study, we showed that human liver material could be better cold-stored as a whole tissue rather than as single cells. This makes it possible for frequent hepatocyte infusions commonly needed in a clinical context.
Cell transplantation is a frequently studied alternative to organ transplantation in liver disease. Many cell types are under extensive evaluation, with primary human hepatocytes and different stem cell types coming first on the list. For primary human hepatocytes, liver tissue is still needed, and when available, cells are produced in huge numbers requiring cryopreservation. Available hepatocyte cryopreservation protocols still need further optimization. In addition, better cold storage techniques for hepatocytes are needed for the feasibility of frequent cell infusions per patient. Stem cells still need to be studied further for their differentiation potential towards hepatic lineages, safety, immunomodulatory roles, and their possible support for co- transplanted hepatocytes.
In this thesis, we addressed a few of the current obstacles facing cellular replacement therapy for liver disease. In the first study, we isolated and characterized a mesenchymal stem cell population from human fetal liver. The hepatic origin, the mesenchymal nature, and the immunomodulatory effects of these cells suggest them as potential candidates for cellular therapy for liver disease. In addition, we transplanted these cells into a mouse model of liver disease with an evidence for their potential differentiation to hepatocyte-like cells in vivo. In the second study, we characterized microRNAs expressed in the human liver. Such information can help understanding the role of microRNAs in liver development and their potential use in microRNA-based stem cell differentiation towards hepatic lineages. In the third study, we introduced a new defined xeno-free cryoprotectant to the field of hepatocyte cryopreservation. This cryoprotectant could be of value when preserving hepatocytes and stem cell-derived hepatocytes in a clinical setting. In the fourth study, we showed that human liver material could be better cold-stored as a whole tissue rather than as single cells. This makes it possible for frequent hepatocyte infusions commonly needed in a clinical context.
List of papers:
I. Saliem M, Ericzon BG, Ellis E, Hovatta O, Götherström C. Isolation and Characterization of Mesenchymal Stem Cells from Human Fetal Liver; Potential Candidates for Replacement Therapy in Liver Disease. Journal of Liver: Disease & Transplantation. 2012;1:2.
Fulltext (DOI)
II. Saliem M, Zhao Y, Greco D, Kere J, Ellis E, Hovatta O, Asikainen S. The Role of MicroRNAs in Hepatocyte Development and Hematopoiesis in Human Fetal and Adult Livers. [Manuscript]
III. Saliem M, Holm F, Tengzelius RB, Jorns C, Nilsson LM, Ericzon BG, Ellis E, Hovatta O. Improved Cryopreservation of Human Hepatocytes Using a New Xeno-free Cryoprotectant Solution. World J Hepatol. 2012;4(5):176-83.
Fulltext (DOI)
Pubmed
IV. Jorns C, Gramignoli R, Saliem M, Zemack H, Mörk LM, Isaksson B, Nowak G, Ericzon BG, Strom S and Ellis E. Strategies for Short-term Storage of Hepatocytes for Repeated Clinical Infusions. Journal Cell Transplant. [Accepted]
Pubmed
View record in Web of Science®
I. Saliem M, Ericzon BG, Ellis E, Hovatta O, Götherström C. Isolation and Characterization of Mesenchymal Stem Cells from Human Fetal Liver; Potential Candidates for Replacement Therapy in Liver Disease. Journal of Liver: Disease & Transplantation. 2012;1:2.
Fulltext (DOI)
II. Saliem M, Zhao Y, Greco D, Kere J, Ellis E, Hovatta O, Asikainen S. The Role of MicroRNAs in Hepatocyte Development and Hematopoiesis in Human Fetal and Adult Livers. [Manuscript]
III. Saliem M, Holm F, Tengzelius RB, Jorns C, Nilsson LM, Ericzon BG, Ellis E, Hovatta O. Improved Cryopreservation of Human Hepatocytes Using a New Xeno-free Cryoprotectant Solution. World J Hepatol. 2012;4(5):176-83.
Fulltext (DOI)
Pubmed
IV. Jorns C, Gramignoli R, Saliem M, Zemack H, Mörk LM, Isaksson B, Nowak G, Ericzon BG, Strom S and Ellis E. Strategies for Short-term Storage of Hepatocytes for Repeated Clinical Infusions. Journal Cell Transplant. [Accepted]
Pubmed
View record in Web of Science®
Institution: Karolinska Institutet
Supervisor: Hovatta, Outi
Issue date: 2013-04-04
Rights:
Publication year: 2013
ISBN: 978-91-7549-055-7
Statistics
Total Visits
Views | |
---|---|
Cellular ...(legacy) | 1862 |
Cellular ... | 815 |
Total Visits Per Month
February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | |
---|---|---|---|---|---|---|---|
Cellular ... | 26 | 40 | 35 | 25 | 16 | 16 | 11 |
File Visits
Views | |
---|---|
Thesis_Saliem.pdf(legacy) | 1083 |
Spikblad_Saliem.pdf(legacy) | 366 |
Thesis_Saliem.pdf | 283 |
Spikblad_Saliem.pdf | 98 |
Thesis_Saliem.pdf.txt(legacy) | 2 |
Spikblad_Saliem.pdf.txt(legacy) | 2 |
Top country views
Views | |
---|---|
United States | 691 |
Germany | 527 |
Ireland | 206 |
Sweden | 191 |
Denmark | 167 |
United Kingdom | 123 |
China | 83 |
Australia | 67 |
South Korea | 62 |
Russia | 29 |
Top cities views
Views | |
---|---|
Kiez | 463 |
Dublin | 205 |
Sydney | 64 |
Ashburn | 62 |
Copenhagen | 60 |
Romeo | 52 |
Ballerup | 49 |
Seoul | 48 |
Sunnyvale | 46 |
Stockholm | 31 |